Cellular immunity in schizophrenic patients before and during neuroleptic treatment

Bresnihan, 1977, Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systematic lupus erythematosus, Journal of Clinical Investigation, 59, 106, 10.1172/JCI108607 Coffey, 1983, T lymphocytes in schizophrenia, Biological Psychiatry, 18, 113 Crow, 1984, A reevaluation of the viral hypothesis: Is psychosis the result of retroviral integration at a site close to the cerebral dominance gene?, British Journal of Psychiatry, 145, 243, 10.1192/bjp.145.3.243 DeLisi, 1982, An analysis of lymphocyte subpopulations in schizophrenic patients, Biological Psychiatry, 17, 1003 DeLisi, 1985, Are there antibodies against brain in sera from schizophrenic patients?, Biological Psychiatry, 20, 94, 10.1016/0006-3223(85)90145-3 Eckstein, 1984, Lymphocyte disorders in immune thrombozytopenic purpura, Blut, 49, 276 Eckstein, 1985, Beeinflussung immunfunktioneller Parameter bei Histiozytose-X durch Thymostimulin, Arzneimmitel-Forschung, 35, 155 Eckstein, 1982, Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis, Circulation, 65, 1224, 10.1161/01.CIR.65.6.1224 Eckstein, 1984, The role of human leukocyte antigen genes and low suppressor cell activity in the pathogenesis of myocarditis and dilated cardiomyopathy, 150 Ellner, 1979, Tuberculin response of lymphocytes from human skin test reactors: Evidence for in vitro primary sensitization of T lymphocytes, Cellular Immunology, 45, 213, 10.1016/0008-8749(79)90379-4 Ferguson, 1978, Effect of psychoactive drugs on in vitro lymphocyte activation, Birth Defects: Original Article Series, 14, 379 Fessel, 1963, The “antibrain” factors in psychiatric patients' sera, Archives of General Psychiatry, 8, 614, 10.1001/archpsyc.1963.01720120088012 Fudenberg, 1971, Genetically determined immune defiency as the predisposing cause of “autoimmunity” and lymphoid neoplasia, American Journal of Medicine, 51, 295, 10.1016/0002-9343(71)90263-4 Ganguli, 1989, Increased serum interleukin 2 receptor concentration in schizophrenic and brain damaged subjects, Archives of General Psychiatry, 46, 292, 10.1001/archpsyc.1989.01810030098018 Ganguli, 1989, Multiple autoantibodies and autoimmune disease in schizophrenic patients: Evidence for an autoimmune pathogenesis, 364 Ganguli, 1987, Clinical and laboratory evidence of autoimmunity in acute schizophrenia, 496, 676 Gelfaud, 1985, Mitogens trigger a calcium independent signal for proliferation in phorbol-ester-treated lymphocytes, Nature, 315, 419, 10.1038/315419a0 Goldstein, 1980, Immunological components in schizophrenia, 249 Heath, 1967, Schizophrenia as an immunological disorder: I. Demonstration of antibrain globulins by flourescent antibody techniques, Archives of General Psychiatry, 39, 82 Henneberg, 1990, T-lymphocyte subpopulations in schizophrenic patients, European Archives of Psychiatry and Neurological Science, 239, 283, 10.1007/BF01735051 Hodgson, 1978, Alteration in suppressor cell activity in chronic active hepatitis, Proceedings of the National Academy of Sciences of the United States of America, 75, 1549, 10.1073/pnas.75.3.1549 Hong, 1988, Studies on immunological changes among schizophrenic patients, Schizophrenia Research, 1, 431, 10.1016/0920-9964(88)90026-6 Huang, 1988, Correlation of T and B cell activities in vitro and serum IL-2 levels in systematic lupus erythematosus, Journal of Immunology, 141, 827, 10.4049/jimmunol.141.3.827 Janossy, 1974, Activation of human T and B lymphocytes by polyclonal mitogens, Nature, 248, 698, 10.1038/248698a0 Kato, 1982, HLA-DR antigens and the rubella-specific immune response in man, Tissue Antigens, 19, 140, 10.1111/j.1399-0039.1982.tb01430.x Kay, 1986, Acquired defect in interleukin-2 production in patients with type I diabetes mellitus, New England Journal of Medicine, 315, 930 Kelly, 1987, Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia, Biological Psychiatry, 22, 1488, 10.1016/0006-3223(87)90110-7 Knight, 1982, Dopamine-receptor-stimulating autoantibodies, a possible cause of schizophrenia, Lancet, II, 1073, 10.1016/S0140-6736(82)90007-1 Knight, 1987, Is schizophrenia a virally triggered antireceptor autoimmune disease?, 107 Mach, 1983, Schizophrenie und B-Lymphozytenalteration —eine Hypothese, Psychiatrie, Neurologie und Medizinische Psychologie, 35, 390 McAllister, 1989, Effect of short term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients, Archives of General Psychiatry, 46, 956, 10.1001/archpsyc.1989.01810100098019 McAllister, 1989, Increased number of CD5+ B-lymphocytes in schizophrenic patients, Archives of General Psychiatry, 46, 890, 10.1001/archpsyc.1989.01810100032006 McMichael, 1977, The immune response to diphtheria toxoid in humans, Transplantation Proceedings, 9, 191 Müller, 1987, Reduced suppressor cell function in psychiatric patients, 496, 686 Nowell, 1960, Phytohemagglutinin: An inhibitor of mitosis in cultures of normal human leukocytes, Cancer Research, 20, 462 Nyland, 1980, Lymphocyte subpopulations in peripheral blood from schizophrenic patients, Acta Psychiatrica Scandinavica, 61, 313, 10.1111/j.1600-0447.1980.tb00584.x Oie, 1981, Target antigen of vaccinia-infected cells recognized by virus-specific cytotoxic T lymphocytes, Immunology, 25, 361 Overall, 1976, O47 BPRS, Brief Psychiatric Rating Scale, 157 Pandey, 1981, Autoimmune model of schizophrenia with special reference to antibrain antibodies, Biological Psychiatry, 16, 1123 Rabin, 1988, The central nervous system-immune system relationship, Clinics in Laboratory Medicine, 8, 253, 10.1016/S0272-2712(18)30682-6 Rapaport, 1989, Elevated levels of soluble interleukin-2 receptors in schizophrenia, Archives of General Psychiatry, 46, 291, 10.1001/archpsyc.1989.01810030097017 Rich, 1973, Biological expression of lymphocyte activation: II. Generation of a population of thymus derived suppressor lymphocytes, Journal of Experimental Medicine, 137, 649, 10.1084/jem.137.3.649 Rich, 1975, Biological expression of lymphocyte activation: IV. Concanavalin A-activated suppressor lymphocytes, Journal of Immunology, 114, 1112, 10.4049/jimmunol.114.3.1112 Shearer, 1986, A model for the selective loss of major histocompatibility complex self-restricted T-cell immune responses during the development of acquired immune d efiency syndrome (AIDS), Journal of Immunology, 137, 2514, 10.4049/jimmunol.137.8.2514 Shou, 1976, Suppressor cell activity after concanavalin A-treatment of lymphocytes from normal donors, Journal of Experimental Medicine, 143, 1100, 10.1084/jem.143.5.1100 Talal, 1980, Progress in the mechanisms of autoimmune disease Vartanian, 1987, A psychiatrist's view of neuroimmunomodulation: The neuroimmune interactionand mechanisms, 496, 660 Villemain, 1989, Aberrant T cell-mediated immunity in untreated schizophrenic patients: Deficient interleukin-2 production, American Journal of Psychiatry, 146, 609, 10.1176/ajp.146.5.609 Villemain, 1987, Decreased production of interleukin-2 in schizophrenia, 496, 669 Weksler, 1980, The immune system and the aging process in man, Proceedings of the Society for Experimental Biology and Medicine, 165, 200, 10.3181/00379727-165-40958